Breast Cancer,HER2- Palbociclib and Endocrine Therapy for Metastatic Breast Cancer Patients May 19, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Improved OS in Postmenopausal HR+/HER2- ABC Patients With RIB and FUL Apr 28, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Breakthrough in Triple Negative Breast Cancer Treatment: GeparNuevo Study Apr 28, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Talazoparib Monotherapy for Homologous Recombination Gene Mutations Apr 28, 2023
Breast Cancer,HER2- Comparison of PAL + FUL vs. CAPE in the GEICAM/2013-02 (PEARL) Phase 3 Trial Mar 28, 2023
Breast Cancer,HER2- Cardiac Impact: Trastuzumab Emtansine vs Paclitaxel+Trastuzumab for HER2+ Breast Cancer Mar 27, 2023
Breast Cancer,HER2- Safety Analysis of Palbociclib with Fulvestrant/Letrozole in HR+/HER2- ABC: PARSIFAL Trial Mar 14, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Adjuvant Olaparib Improves OS in High-Risk EBC: OlympiA Phase III Mar 09, 2023
